- Home
- MNPR vs CTGO Comparison
MNPR vs CTGO Comparison
Compare MNPR & CTGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- CTGO
- Stock Information
- Founded
- MNPR 2014
- CTGO 2009
- Country
- MNPR United States
- CTGO United States
- Employees
- MNPR N/A
- CTGO N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- CTGO Precious Metals
- Sector
- MNPR Health Care
- CTGO Basic Materials
- Exchange
- MNPR Nasdaq
- CTGO Nasdaq
- Market Cap
- MNPR 390.5M
- CTGO 365.7M
- IPO Year
- MNPR 2019
- CTGO N/A
- Fundamental
- Price
- MNPR $86.16
- CTGO $21.46
- Analyst Decision
- MNPR Strong Buy
- CTGO
- Analyst Count
- MNPR 12
- CTGO 0
- Target Price
- MNPR $96.64
- CTGO N/A
- AVG Volume (30 Days)
- MNPR 97.3K
- CTGO 115.1K
- Earning Date
- MNPR 11-10-2025
- CTGO 11-10-2025
- Dividend Yield
- MNPR N/A
- CTGO N/A
- EPS Growth
- MNPR N/A
- CTGO N/A
- EPS
- MNPR N/A
- CTGO N/A
- Revenue
- MNPR N/A
- CTGO N/A
- Revenue This Year
- MNPR N/A
- CTGO N/A
- Revenue Next Year
- MNPR N/A
- CTGO N/A
- P/E Ratio
- MNPR N/A
- CTGO N/A
- Revenue Growth
- MNPR N/A
- CTGO N/A
- 52 Week Low
- MNPR $12.55
- CTGO $8.85
- 52 Week High
- MNPR $105.00
- CTGO $26.88
- Technical
- Relative Strength Index (RSI)
- MNPR 57.75
- CTGO 37.76
- Support Level
- MNPR $77.00
- CTGO $21.01
- Resistance Level
- MNPR $89.32
- CTGO $21.94
- Average True Range (ATR)
- MNPR 7.00
- CTGO 1.14
- MACD
- MNPR -1.45
- CTGO -0.40
- Stochastic Oscillator
- MNPR 44.25
- CTGO 12.01
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About CTGO Contango ORE Inc.
Contango Ore Inc operates in the United States. The company is engaged in the exploration of gold, silver, and copper ores in the State of Alaska. The company's focus is the exploration of a mineral lease with the Native Village of Tetlin whose governmental entity is the Tetlin Tribal Council for the exploration of minerals near Tok, Alaska. It has formed a joint venture to advance exploration of the Tetlin Property, which is prospective for gold and associated minerals. The Peak Gold JV Property is located in the Tetlin Hills and Mentasta Mountains of eastern interior Alaska. Its exploration projects are Lucky Shot, Johnson Tract, Eagle, Hona, Shamrock, and Triple Z.